UK Clinical Trials
The UK has published clinical trial metrics, with 82% of already open studies recruiting participants on schedule, but launch after approval is lagging. On August 19, the UK's Department of Health and Social Care published July metrics for the UKCRD program, which tracks clinical trial timelines.
The program measures the path from application to first participant separately, including the stages of regulatory and ethics committee approval, research center opening, and first participant enrollment. The 82% metric describes recruitment in already open studies, while launch after approval is measured by separate metrics.
In the CPMS registry, a database of the UK's National Institute for Health and Care Research network, there were 4,347 open studies in July, with 82% of them recruiting on schedule and reaching target participant numbers, exceeding the 80% goal. The UKCRD has been publishing these metrics since 2024.
For commercial drug trials, a 150-day metric covers the entire path from application to first participant, with all nine January-submitted studies meeting this timeline. After approval, the report tracks two more stages: 56% of studies opened recruitment within 60 days, and 61% enrolled their first participant within 30 days of opening recruitment, with a 90% goal for both stages, as reported in the UKCRD July metrics.
🔗 Read original →
GOV.UK
UK Clinical Research Delivery key performance indicators: data to July 2026
The UK Clinical Research Delivery (UKCRD) key performance indicators (KPIs) report brings together data from the National Institute for Health and Care Research (NIHR) and the Medicines and Healthcare products Regulatory Agency (MHRA) to monitor the delivery…
August 23, 2026 4
